Romain Ollier
6Patents
2h-index
7Co-inventors
36Inventor score
Filing activity: Nov 4, 2014 → Jun 9, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9493563B2 | Production of T cell retargeting hetero-dimeric immunoglobulins | Chemistry; Metallurgy | 32 | Active |
| US11773166B2 | CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and methods of their production | Chemistry; Metallurgy | 2 | Active |
| US11851502B2 | Production of T cell retargeting hetero-dimeric immunoglobulins | Chemistry; Metallurgy | 1 | Active |
| US11891454B2 | Production of T cell retargeting hetero-dimeric immunoglobulins | Chemistry; Metallurgy | 1 | Active |
| US12006367B2 | CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and methods of their production | Chemistry; Metallurgy | 0 | Active |
| US10640564B2 | Antibodies that bind to CCR6 and their uses | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.